Vigil Neuroscience (VIGL)
(Delayed Data from NSDQ)
$3.25 USD
+0.01 (0.31%)
Updated Aug 8, 2024 04:00 PM ET
After-Market: $3.24 -0.01 (-0.31%) 6:26 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Brokerage Reports
Vigil Neuroscience, Inc. [VIGL]
Reports for Purchase
Showing records 41 - 51 ( 51 total )
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Natural History Data Important for Rare Diseases like ALSP; Reit. Buy and $24 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Reiterate Outperform Rating - Continue to See Differentiation With VGL101
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Reiterate Outperform Rating - Continue to See Differentiation With VGL101
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Target Engagement - Check; Pathway Engagement - Check; On To Phase 2 For VGL101
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Takeaways From Vigil?s Interim Top Line Phase 1 HV Data
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
The Beginning of an Era of Anti-Amyloids and Combination Therapies in Alzheimer''s Disease
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Initiating at Outperform; Making Neurodegenerative Conditions Tremble
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Mobilizing the Vigilantes of the Brain to Tackle Neurodegeneration; Buy and PT $24
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A